Problems viewing this newsletter? View it in your browser >

June 18, 2013

Dear Advocate,

This update contains information on the upcoming IAS Conference on HIV Pathogenesis, Treatment and Prevention taking place June 30–July 3 in Kuala Lumpur, Malaysia. We point out some sessions of interest and review ways to navigate the conference, on-site and online.

Held every two years, the IAS conference includes many sessions on a range of HIV-related topics. Approximately 4,000 scientists, community leaders, public health experts and advocates will meet in the Kuala Lumpur Convention Center.

The full conference schedule is available on the IAS 2013 website along with a number of roadmaps that identify sessions focused on specific issues, including AIDS vaccines and biomedical prevention, treatment as prevention and towards an HIV cure.

In addition, we wanted to be sure to draw your attention to a few sessions taking place at IAS 2013 that are of particular interest to prevention research advocates:

Sunday, June 30

Monday, July 1

Tuesday, July 2

Wednesday, July 3

  • Late Breaker Track C: Prevention Sciences, including results of the recent Bangkok Tenofovir Study, other PrEP research, Implementing Option B+ in Malawi and the Shang Ring non-surgical VMMC device, 16:30–17:30, Session Room 1

For those not attending the conference in person, there are a number of ways to follow along at a distance. Once again NAM/AIDSMAP is the official provider of online scientific reporting from the conference. Clinical Care Options will provide scientific analysis of the news announced in Kuala Lumpur. IAS will be providing “The Daily Bulletin” on their website with news and information from each day of the conference once the proceedings begin. You may also follow their Facebook and Twitter pages. And follow AVAC's Facebook and Twitter pages for real-time updates.

As always, we welcome questions and comments at


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423